Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2169/internalmedicine.56.6856 http://scihub22266oqcxt.onion/10.2169/internalmedicine.56.6856 C5348460!5348460 !28154280     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28154280 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Intern+Med 2017 ; 56 (3 ): 341-346 Nephropedia Template TP {{tp|p=28154280 |t=2017. An Atypical Clinical Course of Anti-MDA5 Antibody-positive Interstitial Lung Disease in a Patient with Three Deteriorations in 9 years |pdf=|usr=}}{{28154280 }} gab.com Text An Atypical Clinical Course of Anti-MDA5 Antibody-positive Interstitial Lung Disease in a Patient with Three Deteriorations in 9 years JO: Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=28154280 #FOAvip Anti-MDA5 antibody-positive patients with clinically amyopathic dermatomyositis (CADM) are at high risk of developing rapidly progressive interstitial lung disease (ILD), which is associated with a high mortality rate. Approximately half of the patients with ILD recover; however, the long-term clinical course of these patients has not been fully reported and is not completely understood. This report describes the atypical clinical course of an anti-MDA5 antibody-positive CADM patient who experienced three deteriorations of ILD in 9 years. These findings indicate that the ILD in anti-MDA5 antibody-positive patients may not only be rapidly progressive, but may also be chronic and recurrent. Twit Text FOAVip An Atypical Clinical Course of Anti-MDA5 Antibody-positive Interstitial Lung Disease in a Patient with Three Deteriorations in 9 years ????Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=28154280 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28154280 #FOAvip English Wikipedia <ref>{{Cite pmid|28154280 }}</ref> An Atypical Clinical Course of Anti-MDA5 Antibody-positive Interstitial Lung Disease in a Patient with Three Deteriorations in 9 years #MMPMID28154280 Sato Y ; Otsuka K ; Tamai K ; Ono Y ; Hamaguchi Y ; Tomii K Intern Med 2017[]; 56 (3 ): 341-346 PMID28154280 show ga Anti-MDA5 antibody-positive patients with clinically amyopathic dermatomyositis (CADM) are at high risk of developing rapidly progressive interstitial lung disease (ILD), which is associated with a high mortality rate. Approximately half of the patients with ILD recover; however, the long-term clinical course of these patients has not been fully reported and is not completely understood. This report describes the atypical clinical course of an anti-MDA5 antibody-positive CADM patient who experienced three deteriorations of ILD in 9 years. These findings indicate that the ILD in anti-MDA5 antibody-positive patients may not only be rapidly progressive, but may also be chronic and recurrent. |Antibodies, Anti-Idiotypic/*immunology [MESH] |DEAD-box RNA Helicases/immunology [MESH] |Dermatomyositis/complications/*immunology [MESH] |Humans [MESH] |Intercellular Signaling Peptides and Proteins [MESH] |Interferon-Induced Helicase, IFIH1/immunology [MESH] |Lung Diseases, Interstitial/complications/diagnosis/*immunology [MESH] |Male [MESH] |Middle Aged [MESH]An Atypical Clinical Course of Anti-MDA5 Antibody-positive Interstitia(epmc).pdf DeepDyve Pubget Overpricing